You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,370,622


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,370,622 protect, and when does it expire?

Patent 9,370,622 protects ZINGO and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 9,370,622
Title:Devices and methods for delivering particles
Abstract: Systems, devices, and methods for delivering therapeutic particles are disclosed. In one variation, a device for delivering particles includes a gas supply configured for supplying gas under pressure, a particle cassette comprising the particles, a cassette housing, and a cassette membrane. The cassette housing can comprise an Ethylene Vinyl Acetate (EVA) copolymer of 18% to 28% by weight of Vinyl Acetate (VA). The device can also include a safety interlock to prevent or minimize the risk that the device will be unintentionally activated. The device can also have a silencer.
Inventor(s): Tsui; Victor K. (Millbrae, CA)
Assignee: Powder Pharmaceuticals Incorporated (HK)
Application Number:14/869,670
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,370,622: A Detailed Analysis

Introduction

Patent 9,370,622, like any other patent, is a complex document that outlines the scope and claims of an invention. To analyze this patent, it is crucial to understand the broader patent landscape, the specific guidelines and regulations governing patent claims, and the recent updates in patent law.

Patent Landscape Overview

The U.S. patent landscape is dynamic, with continuous changes in regulations and guidelines. In 2018, the USPTO awarded 309,000 utility patents, with a significant portion attributed to electrical and mechanical engineering fields[4].

Recent Updates in Patent Law

Recent updates, such as the 2024 USPTO Guidance Update on AI Patent Eligibility, have refined the process for determining the patent eligibility of AI-related inventions. This update emphasizes the integration of judicial exceptions into practical applications and clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility[1].

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention. The scope of a patent is often measured using metrics such as independent claim length and independent claim count. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Enablement and Written Description

The USPTO also provides guidelines for assessing enablement in utility applications, which is crucial for ensuring that the patent claims are supported by sufficient disclosure. This includes the implementation of Supreme Court decisions, such as Amgen Inc. et al. v. Sanofi, to ensure that the claims are enabled and described in the specification[5].

Analyzing Patent 9,370,622

Patent Title and Abstract

To begin, it is essential to review the title and abstract of Patent 9,370,622. The title provides a brief overview of the invention, while the abstract gives a more detailed summary of the invention's purpose and scope.

Claims

The claims section is where the inventor defines the boundaries of the invention. Here, you would look at the independent and dependent claims to understand what is being patented. For example, if the patent involves AI technology, the claims would need to integrate any abstract ideas into practical applications to meet the eligibility criteria[1].

Description of the Invention

The description section provides detailed information about the invention, including how it works and its various components. This section must support the claims and ensure that the invention is enabled and described sufficiently.

Figures and Drawings

Figures and drawings are often included to illustrate the invention. These visual aids can help in understanding the invention's structure and operation.

Evaluating Patent Eligibility

For AI-related inventions like those potentially covered by Patent 9,370,622, the 2024 USPTO Guidance Update is particularly relevant. Here are some key points to consider:

  • Integration into Practical Applications: The claims must integrate judicial exceptions into practical applications. For instance, if the patent involves an artificial neural network, the claims should demonstrate how the neural network is applied in a way that improves technology or provides a practical application[1].

  • AI-Assisted Inventions: The update clarifies that the use of AI in developing the invention does not affect its subject matter eligibility. Instead, the focus is on the claimed invention itself and whether it includes significant human contribution[1].

  • Recent Case Law: The guidance incorporates recent Federal Circuit decisions, ensuring that the application of patent eligibility criteria is consistent with the latest judicial thinking[1].

Examples from the 2024 USPTO Guidance

The USPTO has provided new examples specifically tailored to AI technologies. For instance:

  • Example 47: This example focuses on an artificial neural network designed to identify or detect anomalies. It shows how claims involving specific applications of neural networks can meet the eligibility criteria by demonstrating an improvement in computer technology[1].

  • Example 48: This example highlights the importance of demonstrating real-world applications of the claimed method or system. It illustrates how specifying the use of separated audio components in a real-time speech recognition system can enhance the accuracy of voice commands, thereby meeting the criteria for patent eligibility[1].

Practical Implications

Understanding the scope and claims of Patent 9,370,622 involves applying these guidelines and examples. Here are some practical implications:

  • Drafting Claims: When drafting claims, it is crucial to ensure that they integrate abstract ideas into practical applications. This involves specifying how the invention is applied in a real-world context to provide concrete benefits[1].

  • Support from Specification: The specification must support the claims with sufficient disclosure. This includes detailed descriptions and drawings that enable the invention[5].

  • Legal Consistency: Ensuring that the patent application aligns with recent case law and USPTO guidelines is essential for avoiding section 101 rejections and other legal challenges[1].

Conclusion

Analyzing the scope and claims of Patent 9,370,622 requires a deep understanding of the current patent landscape, recent updates in patent law, and the specific guidelines governing patent eligibility. By focusing on the integration of judicial exceptions into practical applications, ensuring significant human contribution in AI-assisted inventions, and aligning with recent case law, inventors and patent practitioners can better navigate the complexities of patent law.

Key Takeaways

  • Patent Eligibility: Ensure that claims integrate judicial exceptions into practical applications.
  • AI-Assisted Inventions: The use of AI does not impact subject matter eligibility; focus on the claimed invention itself.
  • Recent Case Law: Align patent applications with the latest judicial thinking.
  • Claim Drafting: Specify real-world applications to provide concrete benefits.
  • Specification Support: Ensure sufficient disclosure in the specification to support the claims.

FAQs

Q: How does the 2024 USPTO Guidance Update affect AI-related patent applications? A: The update refines the process for determining patent eligibility of AI-related inventions by emphasizing the integration of judicial exceptions into practical applications and clarifying that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Q: What metrics are used to measure patent scope? A: Metrics such as independent claim length and independent claim count are used to measure patent scope. Narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Q: Why is enablement important in patent applications? A: Enablement ensures that the patent claims are supported by sufficient disclosure in the specification, which is crucial for the validity and enforceability of the patent[5].

Q: Can AI be used as a tool in inventing patentable subject matter? A: Yes, AI can be used as a tool in inventing patentable subject matter, but the focus remains on the claimed invention itself and whether it includes significant human contribution[1].

Q: How do recent Federal Circuit decisions impact patent eligibility criteria? A: Recent Federal Circuit decisions are integrated into the USPTO guidance to ensure consistency and clarity in the application of patent eligibility criteria, reflecting the latest judicial thinking[1].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - NCSES
  5. Guidelines for Assessing Enablement in Utility Applications and Reissue Applications - Federal Register

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,370,622

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 RX No No ⤷  Subscribe ⤷  Subscribe ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,370,622

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015222937 ⤷  Subscribe
China 106163500 ⤷  Subscribe
China 106975128 ⤷  Subscribe
European Patent Office 3110404 ⤷  Subscribe
Japan 2017524384 ⤷  Subscribe
Japan 6369551 ⤷  Subscribe
South Korea 101845648 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.